Where Innovations Meets Personalized and Precision Medicine
Author = Abbasi, Bahareh
Number of Articles: 2
miR-22-3p as a Novel Biomarker in Rheumatoid Arthritis

miR-22-3p as a Novel Biomarker in Rheumatoid Arthritis

Volume 7, Issue 24, 2022, Pages 19-22

https://doi.org/10.22034/pmj.2022.252479

Maryam Hassanpoor, Bahareh Abbasi

Abstract Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune. Early diagnosis of RA remains challenging. A significant portion of RA patients also experience unremitting symptoms despite treatment. miRNA are involved in the regulation of autoimmunity- and inflammation-related processes. In this study, we evaluated the expression of miR-22-3p in serum of RA patients as a novel biomarker. Expression level of this gene in the blood serum of 30 people with RA compared with 30 healthy individuals by the qRT-PCR method. Results showed levels of miR22-3p were significantly higher in the serum of patients with RA in comparison with healthy control (p<0.0001). We suggest that miR 22-3p can be used as a biomarker in early detection and screening.

Investigating the Link Between MS and the EBV Virus

Investigating the Link Between MS and the EBV Virus

Volume 7, Issue 24, 2022, Pages 23-27

https://doi.org/10.22034/pmj.2022.252441

Bahareh Abbasi, Almas Araghi, AmirHossein Akbari Aghababa

Abstract Multiple sclerosis (MS) is a disease of the central nervous system characterized by inflammation, demyelination, and neuronal damage. Epstein–Barr virus (EBV) is a human DNA herpesvirus infecting more than 90% of the world's population. EBV is the etiological agent of infectious mononucleosis (Pfeiffer's disease). Major predisposing factors for MS are certain tissue types (e.g., HLA DRB1*15:01), vitamin D deficiency, smoking, obesity, and infection with Epstein-Barr virus (EBV). This review summarizes current knowledge on the association between EBV and MS.